You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Merck
Express Scripts
Baxter
Colorcon

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for AZD6738

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug AZD6738?

AZD6738 is an investigational drug.

There have been 26 clinical trials for AZD6738. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2018.

The most common disease conditions in clinical trials are Breast Neoplasms, Cholangiocarcinoma, and Carcinoma. The leading clinical trial sponsors are AstraZeneca, Samsung Medical Center, and Institute of Cancer Research, United Kingdom.

There are five US patents protecting this investigational drug and forty-two international patents.

Recent Clinical Trials for AZD6738
TitleSponsorPhase
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerAstraZenecaPhase 2
Olaparib With Ceralasertib in Recurrent OsteosarcomaAstraZenecaPhase 2
Olaparib With Ceralasertib in Recurrent OsteosarcomaOsteosarcoma InstitutePhase 2

See all AZD6738 clinical trials

Clinical Trial Summary for AZD6738

Top disease conditions for AZD6738
Top clinical trial sponsors for AZD6738

See all AZD6738 clinical trials

US Patents for AZD6738

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AZD6738   Start Trial Chemical compounds Astrazeneca AB (Sodertalje, SE)   Start Trial
AZD6738   Start Trial Chemical compounds AstraZeneca AB (Sodertalje, SE)   Start Trial
AZD6738   Start Trial Chemical compounds AstraZeneca AB (Sodertalje, SE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Merck
Express Scripts
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.